4.4 Letter

Intravitreal Anti-Vascular Endothelial Growth Factor Use in France During the Coronavirus Disease 2019 Pandemic

Journal

JAMA OPHTHALMOLOGY
Volume 139, Issue 2, Pages 240-242

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/jamaophthalmol.2020.5594

Keywords

-

Categories

Ask authors/readers for more resources

This cohort study utilizes data from the French National Health Data System to assess the decline in intravitreal anti-vascular endothelial growth factors usage before, during, and after pandemic lockdown periods.
This cohort study uses data from the French National Health Data System to assess the decline in the use of intravitreal anti-vascular endothelial growth factors before, during, and after pandemic-associated lockdown periods.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available